| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
9,390,000 |
| Market
Cap: |
21.78(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.18 - $6.13 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Biostage is a biotechnology company developing bioengineered organ implants based on its Cellframe™ and and Cellspan™ technology. Co.'s technology is comprised of a biocompatible scaffold, which is the foundation of its Cellframe™ technology, that is seeded with the patient's own mesenchymal stromal cells to form its Cellspan™ implant. Co.'s platform technology is being developed to treat life-threatening conditions of the esophagus, bronchus and trachea. Products being developed based on its technology for those indications are called Cellspan™ products. Co.'s primary research and development activities are focused in three areas: materials science, cell biology and engineering.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
5,100 |
24,864 |
175,878 |
| Total Buy Value |
$0 |
$24,885 |
$113,394 |
$1,012,397 |
| Total People Bought |
0 |
1 |
2 |
4 |
| Total Buy Transactions |
0 |
3 |
7 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
134,295 |
| Total Sell Value |
$0 |
$0 |
$0 |
$962,849 |
| Total People Sold |
0 |
0 |
0 |
4 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  He Junli |
Director |
– • – |
2021-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
235,135 |
|
32% |
|
| Dst Capital Llc |
10% Owner |
– – • |
2021-09-01 |
4 |
B |
$2.00 |
$1,000,000 |
D/D |
500,000 |
3,650,000 |
2.45 |
32% |
|
| Dst Capital Llc |
10% Owner |
– – • |
2021-06-17 |
4 |
B |
$2.00 |
$300,000 |
D/D |
150,000 |
3,150,000 |
2.45 |
152% |
|
| Chakoutis Peter M |
Vice President of Finance |
• – – |
2020-05-14 |
4 |
D |
$3.13 |
$8,905 |
D/D |
(2,845) |
23,793 |
|
- |
|
| Chakoutis Peter M |
Vice President of Finance |
• – – |
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
26,638 |
|
- |
|
| Chakoutis Peter M |
Vice President of Finance |
• – – |
2020-04-28 |
4 |
D |
$3.05 |
$9,629 |
D/D |
(3,157) |
16,638 |
|
- |
|
| Chakoutis Peter M |
Vice President of Finance |
• – – |
2020-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
19,795 |
|
- |
|
| Chakoutis Peter M |
Vice President of Finance |
• – – |
2020-03-27 |
4 |
D |
$4.00 |
$20,820 |
D/D |
(5,205) |
9,795 |
|
- |
|
| Chakoutis Peter M |
Vice President of Finance |
• – – |
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| Young Jeffrey E |
Director |
– • – |
2019-09-30 |
4 |
OE |
$2.00 |
$50,000 |
D/D |
25,000 |
25,000 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
|
|
